John J. Kirby
CIK 1556327 · Interim CFO · last filed 2025-12-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$108.7K
Companies
4
Total Filings
23
Lifetime Open-Market Net
-$1.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | Interim CFO | 18,962 | $5.73 | $108.7K | $15.0K | 3 | 2025-12-30 |
| Aceragen, Inc. (ACGN) Delisted | CHIEF FINANCIAL OFFICER | — | $0.38 | — | $0 | 1 | 2023-02-02 |
| Aceragen, Inc. (IDRA) Delisted | CHIEF FINANCIAL OFFICER | 436,850 | $7.22 | $3.16M | -$16.5K | 15 | 2023-01-10 |
| VIROPHARMA INC (VPHM) Delisted | V.P., Chief Accounting Officer | — | — | — | $0 | 3 | 2013-06-12 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-06-12 | VIROPHARMA INC (VPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-07 | VIROPHARMA INC (VPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-22 | VIROPHARMA INC (VPHM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.